SGO: Angiogenesis Inhibitor Scores Split Decision (CME/CE)

posted on Mar 22 by in the Uncategorized category SAN FRANCISCO (MedPage Today) -- An investigational angiogenesis inhibitor produced mixed signals in two small clinical trials involving patients with advanced ovarian cancer.

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes